Poloxamer gel adjuvant for O-typed foot and mouth disease polypeptides
A technology for poloxamer gel and foot-and-mouth disease, which is applied in the directions of antiviral agents, aerosol delivery, medical preparations containing active ingredients, etc. Achieve the effect of prolonging the release time of the polypeptide, improving the immune titer, good biocompatibility and safety
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0018] The present invention will be further described in detail below in combination with specific embodiments.
[0019] O-type foot-and-mouth disease peptide antigen (provided by Shenlian Biomedical (Shanghai) Co., Ltd.), concentration 7.88 mg / mL; Poloxamer 407 and Poloxamer 188 (purchased from BASF (China) Co., Ltd.).
[0020] The amount of raw materials used in the preparation of poloxamer gel adjuvant in Examples 1 to 5 is shown in Table 1:
[0021] Table 1
[0022]
Example 1
Example 2
Example 3
Example 4
Example 5
Poloxamer 407 / g
1.9
2.3
2.0
2.1
2.2
Poloxamer 188 / g
0.1
0.8
0.3
0.5
0.6
Deionized water / mL
10
10
10
10
10
Critical gelling temperature / ℃
34.8
34.9
34.9
34.2
35.0
37℃ gel viscosity / Pas
794.3
422.1
526.4
628.7
798.6
Gel viscosity at 25℃ / Pas
21.31
0.111
12.17
24.59
21.71
...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com